-
1
-
-
84873291018
-
Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD biosynthesis, in human cancer cells: Metabolic basis and potential clinical implications
-
Tan B, Young DA, Lu ZH, Wang T, Meier TI, et al. (2013) Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD biosynthesis, in human cancer cells: metabolic basis and potential clinical implications. J Biol Chem 288: 3500-3511.
-
(2013)
J Biol Chem
, vol.288
, pp. 3500-3511
-
-
Tan, B.1
Young, D.A.2
Lu, Z.H.3
Wang, T.4
Meier, T.I.5
-
2
-
-
62649156291
-
NAMPTNAMPTNAMPT: Linking NAD biology, metabolism, and cancer
-
Garten A, Petzold S, Körner A, Imai S-i, Kiess W (2009) NAMPTNAMPTNAMPT: Linking NAD biology, metabolism, and cancer. Trends Endocrinol Metab 20: 130-138.
-
(2009)
Trends Endocrinol Metab
, vol.20
, pp. 130-138
-
-
Garten, A.1
Petzold, S.2
Körner, A.3
S-i, I.4
Kiess, W.5
-
3
-
-
62149150332
-
Niacin status, NAD distribution and ADP-ribose metabolism
-
Kirkland JB (2009) Niacin status, NAD distribution and ADP-ribose metabolism. Curr Pharm Des 15: 3-11.
-
(2009)
Curr Pharm des
, vol.15
, pp. 3-11
-
-
Kirkland, J.B.1
-
4
-
-
1642458398
-
Enzymology of NAD+ homeostasis in man
-
Magni G, Amici A, Emanuelli M, Orsomando G, Raffaelli N, et al. (2004) Enzymology of NAD+ homeostasis in man. Cell Mol Life Sci 61: 19-34.
-
(2004)
Cell Mol Life Sci
, vol.61
, pp. 19-34
-
-
Magni, G.1
Amici, A.2
Emanuelli, M.3
Orsomando, G.4
Raffaelli, N.5
-
5
-
-
40849119972
-
NAD+ and vitamin B3: From metabolism to therapies
-
Sauve AA (2008) NAD+ and vitamin B3: from metabolism to therapies. J Pharmacol Exp Ther 324: 883-893.
-
(2008)
J Pharmacol Exp Ther
, vol.324
, pp. 883-893
-
-
Sauve, A.A.1
-
6
-
-
77953408297
-
A preclinical study on the rescue of normal tissue by nicotinic acid in high dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor
-
Olesen UH, Thougaard AV, Jensen PB, Sehested M (2010) A preclinical study on the rescue of normal tissue by nicotinic acid in high dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor. Mol Cancer Ther 9: 1609-1617.
-
(2010)
Mol Cancer Ther
, vol.9
, pp. 1609-1617
-
-
Olesen, U.H.1
Thougaard, A.V.2
Jensen, P.B.3
Sehested, M.4
-
7
-
-
38649096263
-
Anticancer agent CHS-828 inhibits cellular synthesis of NAD
-
Olesen UH, Christensen MK, Björkling F, Jäättelä M, Jensen PB, et al. (2008) Anticancer agent CHS-828 inhibits cellular synthesis of NAD. Biochem Biophys Res Commun 367: 799-804.
-
(2008)
Biochem Biophys Res Commun
, vol.367
, pp. 799-804
-
-
Olesen, U.H.1
Christensen, M.K.2
Björkling, F.3
Jäättelä, M.4
Jensen, P.B.5
-
8
-
-
70350538957
-
The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: Strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors
-
Watson M, Roulston A, Bélec L, Billot X, et al. (2009) The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors. Mol Cell Biol 29: 5872-5888.
-
(2009)
Mol Cell Biol
, vol.29
, pp. 5872-5888
-
-
Watson, M.1
Roulston, A.2
Bélec, L.3
Billot, X.4
-
9
-
-
0027958452
-
Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony enhancing factor
-
Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I (1994) Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony enhancing factor. Mol Cell Biol 14: 1431-1437.
-
(1994)
Mol Cell Biol
, vol.14
, pp. 1431-1437
-
-
Samal, B.1
Sun, Y.2
Stearns, G.3
Xie, C.4
Suggs, S.5
McNiece, I.6
-
10
-
-
10944270187
-
The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells
-
Revollo JR, Grimm AA, Imai S (2004) The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 279: 50754-50763.
-
(2004)
J Biol Chem
, vol.279
, pp. 50754-50763
-
-
Revollo, J.R.1
Grimm, A.A.2
Imai, S.3
-
11
-
-
58149316660
-
Nicotinamide phosphoribosyl transferase/pre-B cell colony-enhancing factor/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress
-
Rongvaux A, Galli M, Denanglaire S, Van Gool F, Drèze PL, et al. (2008) Nicotinamide phosphoribosyl transferase/pre-B cell colony-enhancing factor/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress. J Immunol 181: 4685-4695.
-
(2008)
J Immunol
, vol.181
, pp. 4685-4695
-
-
Rongvaux, A.1
Galli, M.2
Denanglaire, S.3
Van Gool, F.4
Drèze, P.L.5
-
12
-
-
62149148872
-
Nicotinamide phosphoribosyltransferase (NAMPT). A link between NAD biology, metabolism, and diseases
-
Imai S (2009) Nicotinamide phosphoribosyltransferase (NAMPT). A link between NAD biology, metabolism, and diseases. Curr Pharm Des 15: 20-28.
-
(2009)
Curr Pharm des
, vol.15
, pp. 20-28
-
-
Imai, S.1
-
13
-
-
34248357083
-
Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery
-
Khan JA, Forouhar F, Tao X, Tong L (2007) Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery. Expert Opin Ther Targets 11: 695-705.
-
(2007)
Expert Opin Ther Targets
, vol.11
, pp. 695-705
-
-
Khan, J.A.1
Forouhar, F.2
Tao, X.3
Tong, L.4
-
14
-
-
44449124774
-
Pre-B cell colony-enhancing factor (PBEF)/visfatin: A novel mediator of innate immunity
-
Luk T, Malam Z, Marshall JC. (2008) Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J Leukoc Biol 83: 804-816
-
(2008)
J Leukoc Biol
, vol.83
, pp. 804-816
-
-
Luk, T.1
Malam, Z.2
Marshall, J.C.3
-
15
-
-
80053142651
-
Overexpression of NAMPT in gastric cancer and chemopotentiating effects of the NAMPT inhibitor FK866 in combination with fluorouracil
-
Bi TQ, Che XM, Liao XH., Zhang DJ, Long HL, et al. (2011) Overexpression of NAMPT in gastric cancer and chemopotentiating effects of the NAMPT inhibitor FK866 in combination with fluorouracil. Oncol Rep 26: 1251-1257.
-
(2011)
Oncol Rep
, vol.26
, pp. 1251-1257
-
-
Bi, T.Q.1
Che, X.M.2
Liao, X.H.3
Zhang, D.J.4
Long, H.L.5
-
16
-
-
0033461164
-
A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization
-
Hufton SE, Moerkerk PT, Brandwijk R, de Bruïne AP, Arends JW, et al. (1999) A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization. FEBS Lett 463: 77-82.
-
(1999)
FEBS Lett
, vol.463
, pp. 77-82
-
-
Hufton, S.E.1
Moerkerk, P.T.2
Brandwijk, R.3
De Bruïne, A.P.4
Arends, J.W.5
-
17
-
-
0037056219
-
Target validation for genomics using peptide-specific phage antibodies: A study of five gene products overexpressed in colorectal cancer
-
Van Beijnum JR, Moerkerk PT, Gerbers AJ, De Bruïne AP, Arends JW, et al. (2002) Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer. Int J Cancer 101: 118-127.
-
(2002)
Int J Cancer
, vol.101
, pp. 118-127
-
-
Van Beijnum, J.R.1
Moerkerk, P.T.2
Gerbers, A.J.3
De Bruïne, A.P.4
Arends, J.W.5
-
18
-
-
79952007931
-
NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response
-
Wang B, Hasan MK, Alvarado E, Yuan H, Wu H, et al. (2011) NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response. Oncogene 30: 907-921.
-
(2011)
Oncogene
, vol.30
, pp. 907-921
-
-
Wang, B.1
Hasan, M.K.2
Alvarado, E.3
Yuan, H.4
Wu, H.5
-
19
-
-
68149092537
-
Adipocytokine levels in gastric cancer patients: Resistin and visfatin as biomarkers of gastric cancer
-
Nakajima TE, Yamada Y, Hamano T, Furuta K, Gotoda T, et al. (2009) Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer. J Gastroenterol 44: 685-690.
-
(2009)
J Gastroenterol
, vol.44
, pp. 685-690
-
-
Nakajima, T.E.1
Yamada, Y.2
Hamano, T.3
Furuta, K.4
Gotoda, T.5
-
20
-
-
48249105497
-
Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD
-
Busso N, Karababa M, Nobile M, Rolaz A, Van Gool F, et al. (2008) Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. PLoS One 3: e2267.
-
(2008)
PLoS One
, vol.3
, pp. e2267
-
-
Busso, N.1
Karababa, M.2
Nobile, M.3
Rolaz, A.4
Van Gool, F.5
-
21
-
-
0242526050
-
FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis
-
Hasmann M, Schemainda I (2003) FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res 63: 7436-7442.
-
(2003)
Cancer Res
, vol.63
, pp. 7436-7442
-
-
Hasmann, M.1
Schemainda, I.2
-
22
-
-
34548627517
-
Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival
-
Yang H, Yang T, Baur JA, Perez E, Carmona JJ, et al. (2007) Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130: 1095-1107.
-
(2007)
Cell
, vol.130
, pp. 1095-1107
-
-
Yang, H.1
Yang, T.2
Baur, J.A.3
Perez, E.4
Carmona, J.J.5
-
23
-
-
0842333189
-
Antiangiogenic potency of FK866/K22.175, a new inhibitor of intracellular NAD biosynthesis, in murine renal cell carcinoma
-
Drevs J, Löser R, Rattel B, Esser N (2003) Antiangiogenic potency of FK866/K22.175, a new inhibitor of intracellular NAD biosynthesis, in murine renal cell carcinoma. Anticancer Res 23: 4853-4858.
-
(2003)
Anticancer Res
, vol.23
, pp. 4853-4858
-
-
Drevs, J.1
Löser, R.2
Rattel, B.3
Esser, N.4
-
24
-
-
18244376911
-
Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled 31P magnetic resonance spectroscopy
-
Muruganandham M, Alfieri AA, Matei C, Chen Y, Sukenick G, et al. (2005) Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled 31P magnetic resonance spectroscopy. Clin Cancer Res 11: 3503-3513.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 3503-3513
-
-
Muruganandham, M.1
Alfieri, A.A.2
Matei, C.3
Chen, Y.4
Sukenick, G.5
-
25
-
-
0038043242
-
Intramitochondrial poly(ADP-ribosylation) contributes to NAD depletion and cell death induced by oxidative stress
-
Du L, Zhang X, Han YY, Burke NA, Kochanek PM, et al. (2003) Intramitochondrial poly(ADP-ribosylation) contributes to NAD depletion and cell death induced by oxidative stress. J Biol Chem 278: 18426-18433.
-
(2003)
J Biol Chem
, vol.278
, pp. 18426-18433
-
-
Du, L.1
Zhang, X.2
Han, Y.Y.3
Burke, N.A.4
Kochanek, P.M.5
-
26
-
-
30044443515
-
Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD depletion and reduced Sir2 deacetylase activity
-
Pillai JB, Isbatan A, Imai S, Gupta MP (2005) Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD depletion and reduced Sir2 deacetylase activity. J Biol Chem 280: 43121-43130.
-
(2005)
J Biol Chem
, vol.280
, pp. 43121-43130
-
-
Pillai, J.B.1
Isbatan, A.2
Imai, S.3
Gupta, M.P.4
-
27
-
-
0037067317
-
Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor
-
Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, et al. (2002) Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297: 259-263.
-
(2002)
Science
, vol.297
, pp. 259-263
-
-
Yu, S.W.1
Wang, H.2
Poitras, M.F.3
Coombs, C.4
Bowers, W.J.5
-
28
-
-
0035913911
-
Negative control of p53 by Sir2 promotes cell survival under stress
-
Luo J, Nikolaev AY, Imai S, Chen D, Su F, et al. (2001) Negative control of p53 by Sir2 promotes cell survival under stress. Cell 107: 137-148.
-
(2001)
Cell
, vol.107
, pp. 137-148
-
-
Luo, J.1
Nikolaev, A.Y.2
Imai, S.3
Chen, D.4
Su, F.5
-
29
-
-
34547875773
-
Sirtuins: Critical regulators at the crossroads between cancer and aging
-
Saunders LR, Verdin E. (2007) Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene 26: 5489-5504.
-
(2007)
Oncogene
, vol.26
, pp. 5489-5504
-
-
Saunders, L.R.1
Verdin, E.2
-
30
-
-
59649117804
-
Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin dependent manner
-
Van Gool F, Gallí M, Gueydan C, Kruys V, Prevot PP, et al. (2009) Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin dependent manner. Nat Med 15: 206-210.
-
(2009)
Nat Med
, vol.15
, pp. 206-210
-
-
Van Gool, F.1
Gallí, M.2
Gueydan, C.3
Kruys, V.4
Prevot, P.P.5
-
31
-
-
77958569431
-
Inhibition of nicotinamide phosphoribosyltransferase: Cellular bioenergetics reveals a mitochondrial insensitive NAD pool
-
Pittelli M, Formentini L, Faraco G, Lapucci A, Rapizzi E, et al. (2010) Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool. J Biol Chem 285: 34106-34114.
-
(2010)
J Biol Chem
, vol.285
, pp. 34106-34114
-
-
Pittelli, M.1
Formentini, L.2
Faraco, G.3
Lapucci, A.4
Rapizzi, E.5
-
32
-
-
33745817828
-
Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents
-
Khan JA, Tao X, Tong L (2006) Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents. Nat Struct Mol Biol 13: 582-588.
-
(2006)
Nat Struct Mol Biol
, vol.13
, pp. 582-588
-
-
Khan, J.A.1
Tao, X.2
Tong, L.3
-
33
-
-
65149084441
-
The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies
-
Nahimana A, Attinger A, Aubry D, Greaney P, Ireson C, et al. (2009) The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies. Blood 113: 3276-3286.
-
(2009)
Blood
, vol.113
, pp. 3276-3286
-
-
Nahimana, A.1
Attinger, A.2
Aubry, D.3
Greaney, P.4
Ireson, C.5
-
34
-
-
38149105811
-
The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor
-
Holen K, Saltz LB, Hollywood E, Burk K, Hanauske AR (2008) The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor. Invest New Drugs 26: 45-51.
-
(2008)
Invest New Drugs
, vol.26
, pp. 45-51
-
-
Holen, K.1
Saltz, L.B.2
Hollywood, E.3
Burk, K.4
Hanauske, A.R.5
-
35
-
-
84881367747
-
Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors
-
Galli U, Travelli C, Massarotti A, Fakhfouri G, et al. (2013) Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. J Med Chem 56: 6279-6296.
-
(2013)
J Med Chem
, vol.56
, pp. 6279-6296
-
-
Galli, U.1
Travelli, C.2
Massarotti, A.3
Fakhfouri, G.4
-
36
-
-
47649094272
-
Synthesis and biological evaluation of isosteric analogues of FK866, an inhibitor of NAD salvage
-
Galli U, Ercolano E, Carraro L, Blasi Roman CR, Sorba G, et al. (2008) Synthesis and biological evaluation of isosteric analogues of FK866, an inhibitor of NAD salvage. Chem Med Chem 3: 771-779.
-
(2008)
Chem Med Chem
, vol.3
, pp. 771-779
-
-
Galli, U.1
Ercolano, E.2
Carraro, L.3
Blasi Roman, C.R.4
Sorba, G.5
-
38
-
-
78650723984
-
Pattern recognition and pathway analysis with genetic algorithms in mass spectrometry based metabolomics
-
Zou W, Tolstikov V (2009). Pattern recognition and pathway analysis with genetic algorithms in mass spectrometry based metabolomics. Algorithms 2: 638-666.
-
(2009)
Algorithms
, vol.2
, pp. 638-666
-
-
Zou, W.1
Tolstikov, V.2
-
39
-
-
77049086563
-
Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer
-
Urayama S, Zou W, Brooks K, Tolstikov V (2010). Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer. Rapid Commun Mass Spectrom 24: 613-620.
-
(2010)
Rapid Commun Mass Spectrom
, vol.24
, pp. 613-620
-
-
Urayama, S.1
Zou, W.2
Brooks, K.3
Tolstikov, V.4
-
40
-
-
84915761643
-
-
June 9-13 Paper presented at: ASMS, Minneapolis, MN
-
Tolstikov V, Nikolayev A, Laska AD, Kuo M-S, Duffin KL (2013, June 9-13) Metabolomics input in a search for chronic kidney disease targets utilizing clinical cross-platform omics data integration. Paper presented at: ASMS, Minneapolis, MN.
-
(2013)
Metabolomics Input in a Search for Chronic Kidney Disease Targets Utilizing Clinical Cross-platform Omics Data Integration
-
-
Tolstikov, V.1
Nikolayev, A.2
Laska, A.D.3
Kuo, M.-S.4
Duffin, K.L.5
-
41
-
-
80053427408
-
Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry
-
Chan ECY, Pasikanti KK, Nicholson JK (2011) Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry. Nature Protocols 6: 1483-1499.
-
(2011)
Nature Protocols
, vol.6
, pp. 1483-1499
-
-
Chan, E.C.Y.1
Pasikanti, K.K.2
Nicholson, J.K.3
-
42
-
-
79959913950
-
Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry
-
Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, et al. (2011) Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nature Protocols 6: 1060-1083.
-
(2011)
Nature Protocols
, vol.6
, pp. 1060-1083
-
-
Dunn, W.B.1
Broadhurst, D.2
Begley, P.3
Zelena, E.4
Francis-McIntyre, S.5
-
43
-
-
84860352139
-
A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue
-
Yuan M, Breitkopf SB, Yang X, Asara JM (2012) A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nature Protocols 7: 872-881.
-
(2012)
Nature Protocols
, vol.7
, pp. 872-881
-
-
Yuan, M.1
Breitkopf, S.B.2
Yang, X.3
Asara, J.M.4
-
44
-
-
77952205557
-
Global metabolic profiling procedures for urine using UPLC-MS
-
Want EJ, Wilson ID, Gika H, Theodoridis G, Plumb RS, Shockcor J, Holmes E, Nicholson JK (2010) Global metabolic profiling procedures for urine using UPLC-MS. Nature Protocols 5: 1005-1018.
-
(2010)
Nature Protocols
, vol.5
, pp. 1005-1018
-
-
Want, E.J.1
Wilson, I.D.2
Gika, H.3
Theodoridis, G.4
Plumb, R.S.5
Shockcor, J.6
Holmes, E.7
Nicholson, J.K.8
-
45
-
-
84864479791
-
MetaboAnalyst 2.0 - A comprehensive server for metabolomic data analysis
-
Xia J, Mandal R, Sinelnikov IV, Broadhurst D, Wishart DS (2012) MetaboAnalyst 2.0 - a comprehensive server for metabolomic data analysis. Nucl Acids Res 40: W127-W133.
-
(2012)
Nucl Acids Res
, vol.40
, pp. W127-W133
-
-
Xia, J.1
Mandal, R.2
Sinelnikov, I.V.3
Broadhurst, D.4
Wishart, D.S.5
-
46
-
-
84887050309
-
Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618
-
Xiao Y, Elkins K, Durieux JK, Lee L, Oeh J, et al. (2013) Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618. Neoplasia 15: 1151-1160.
-
(2013)
Neoplasia
, vol.15
, pp. 1151-1160
-
-
Xiao, Y.1
Elkins, K.2
Durieux, J.K.3
Lee, L.4
Oeh, J.5
-
47
-
-
84890345210
-
Inhibition of mitochondrial pyruvate transport by zaprinast causes massive accumulation of aspartate at the expense of glutamate in the retina
-
Du J, Cleghorn WM, Contreras L, Lindasy K, Rountree AM, et al. (2013). Inhibition of mitochondrial pyruvate transport by zaprinast causes massive accumulation of aspartate at the expense of glutamate in the retina. J Biol Chem 288: 36129-36140.
-
(2013)
J Biol Chem
, vol.288
, pp. 36129-36140
-
-
Du, J.1
Cleghorn, W.M.2
Contreras, L.3
Lindasy, K.4
Rountree, A.M.5
-
48
-
-
84863090408
-
Nicotinamide phosphoribosyl transferase (NAMPT) is required for de novo lipogenesis in tumor cells
-
Bowlby SC, Thomas MJ, D'Agostino RB Jr, Kridel SJ (2012) Nicotinamide phosphoribosyl transferase (NAMPT) is required for de novo lipogenesis in tumor cells. PLoS One 7: e40195.
-
(2012)
PLoS One
, vol.7
, pp. e40195
-
-
Bowlby, S.C.1
Thomas, M.J.2
D'Agostino, R.B.3
Kridel, S.J.4
|